Annexin A5 increases the cell surface expression and the chloride channel function of the ΔF508-cystic fibrosis transmembrane regulator

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 10, 2008, Pages 605-614

  Le Drévo, Marie Anne ^a,b,c   Benz, Nathalie ^a,b,c   Kerbiriou, Mathieu ^a,b,c   Giroux Metges, Marie Agnès ^b   Pennec, Jean Pierre ^b   Trouvé, Pascal ^a,b,c   Férec, Claude ^a,b,c,d  

^a INSERM   (France)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d CHU MORVAN   (France)

Author keywords

Annexin A5; CFTR; CFTR function; Cystic fibrosis; Protein interaction

Indexed keywords

CALCIUM ION; CHLORIDE CHANNEL; LIPOCORTIN 5; MUTANT PROTEIN; PHENYLALANINE; THAPSIGARGIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ANNEXIN A5; BLOTTING, WESTERN; CALCIUM; CELL LINE, TUMOR; CELL MEMBRANE; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOPLASM; EPITHELIAL CELLS; HUMANS; IMMUNOPRECIPITATION; ION CHANNEL GATING; MEMBRANE POTENTIALS; MUTATION; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; RNA INTERFERENCE; THAPSIGARGIN; TRANSFECTION;

EID: 52349101983     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.08.002     Document Type: Article

References (53)

1. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., and Chou J.L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
2. Rommens J.M., Iannuzzi M.C., Kerem B., Drumm M.L., Melmer G., Dean M., Rozmahel R., Cole J.L., Kennedy D., Hidaka N., Zciga M., Buchwald M., Riordan J.R., Tsui L.C., and Collins F.S. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245 (1989) 1059-1065
3. Tsui L.C. Tracing the mutations in cystic fibrosis by means of closely linked DNA markers. Am. J. Hum. Genet. 44 (1989) 303-306
4. Gadsby D.C., and Nairn A.C. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol. Rev. 79 (1999) S77-S107
5. Quinton P.M. Physiological basis of cystic fibrosis: a historical perspective. Physiol. Rev. 79 (1999) S3-S22
6. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 329 (1993) 1308-1313
7. Welsh M.J., and Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73 (1993) 1251-1254
8. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O'Riordan C.R., and Smith A.E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63 (1990) 827-834
9. Ward C.L., Omura S., and Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83 (1995) 121-127
10. Pind S., Riordan J.R., and Williams D.B. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269 (1994) 12784-12788
11. Yang Y., Janich S., Cohnand J.A., and Wilson J.M. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9480-9484
12. Heda G.D., Tanwani M., and Marino C.R. The Delta F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells. Am. J. Physiol. Cell Physiol. 280 (2001) C166-C174
13. Li C., Ramjeesingh M., Reyes E., Jensen T., Chang X., Rommens J.M., and Bear C.E. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat. Genet. 3 (1993) 311-316
14. Sharma M., Benharouga M., Hu W., and Lukacs G.L. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J. Biol. Chem. 276 (2001) 8942-8950
15. Rubenstein R.C., and Zeitlin P.L. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am. J. Respir. Crit. Care Med. 157 (1998) 484-490
16. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., and Welsh M.J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358 (1992) 761-764
17. Sato S., Ward C.L., Krouse M.E., Wine J.J., and Kopito R.R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271 (1996) 635-638
18. Illek B., Fischer H., Santos G.F., Widdicombe J.H., Machen T.E., and Reenstra W.W. cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. Am. J. Physiol. 268 (1995) C886-C893
19. Egan M.E., Glockner-Pagel J., Ambrose C., Cahill P.A., Pappoe L., Balamuth N., Cho E., Canny S., Wagner C.A., Geibel J., and Caplan M.J. Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8 (2002) 485-492
20. Lytton J., Westlin M., and Hanley M.R. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem. 266 (1991) 17067-17071
21. Cormet-Boyaka E., Di A., Chang S.Y., Naren A.P., Tousson A., Nelson D.J., and Kirk K.L. CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12477-12482
22. Raghuram V., Mak D.D., and Foskett J.K. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1300-1305
23. Short D.B., Trotter K.W., Reczek D., Kreda S.M., Bretscher A., Boucher R.C., Stutts M.J., and Milgram S.L. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J. Biol. Chem. 273 (1998) 19797-19801
24. Wang S., Yue H., Derin R.B., Guggino W.B., and Li M. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 103 (2000) 169-179
25. Cheng J., Moyer B.D., Milewski M., Loffing J., Ikeda M., Mickle J.E., Cutting G.R., Li M., Stanton B.A., and Guggino W.B. A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J. Biol. Chem. 277 (2002) 3520-3529
26. Trouvé P., Le Drévo M.A., Kerbiriou M., Friocourt G., Fichou Y., Gillet D., and Férec C. Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's function, BBA-Molecular Basis of Disease. Biochim. Biophys. Acta 1772 (2007) 1121-1133
27. Crumpton M.J., and Dedman J.R. Protein terminology tangle. Nature 345 (1990) 212
28. Ikebuchi N.W., and Waisman D.M. Calcium-dependent regulation of actin filament bundling by lipocortin-85. J. Biol. Chem. 265 (1990) 3392-3400
29. Funakoshi T., Heimark R.L., Hendrickson L.E., McMullen B.A., and Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry 26 (1987) 5572-5578
30. Mira J.P., Dubois T., Oudinet J.P., Lukowski S., Russo-Marie F., and Geny B. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J. Biol. Chem. 272 (1997) 10474-10482
31. Camors E., Charue D., Trouvé P., Monceau V., Loyer X., Russo-Marie F., and Charlemagne D. Association of annexin A5 with Na+/Ca2+exchanger and caveolin-3 in non-failing and failing human heart. J. Mol. Cell Cardiol. 40 (2006) 47-55
32. Mukhopadhyay S., and Cho W. Interactions of annexin V with phospholipid monolayers. Biochim. Biophys. Acta. 1279 (1996) 58-62
33. 2+channels in phosphatidylserine bilayer membranes. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2974-2978
34. Lambert O., Cavusoglu N., Gallay J., Vincent M., Rigaud J.L., Henry J.P., and Ayala-Sanmartin J. Novel organization and properties of annexin 2-membrane complexes. J. Biol. Chem. 279 (2004) 10872-10882
35. Norez C., Antigny F., Becq F., and Vandebrouck C. Maintaining low Ca2+level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells. Traffic 7 (2006) 562-573
36. Hakansson A., Zhivotovsky B., Orrenius S., Sabharwal H., and Svanborg C. Apoptosis induced by a human milk protein. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8064-8068
37. Cozens A.L., Yessi M.J., Kunzelmann K., Ohrui T., Chin L., Eng K., Finkbeiner W.E., Widdicome J.H., and Gruenert D.C. CFTR expression and Chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10 (1994) 38-47
38. Bruscia E., Sangiuolo F., Goncz K.K., Novelli G., and Gruenert D.C. Isolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting. Gene Ther. 9 (2002) 683-685
39. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
40. Leblais V., Demolombe S., Vallette G., Langin D., Baro I., Escande D., and Gauthier C. β3-adrenoreceptor control the CFTR conductance through a cAMP/PKA-independent pathway. J. Biol. Chem. 274 (1999) 6107-6113
41. Kerbiriou M., Le Drévo M.A., Férec C., and Trouvé P. Coupling cystic fibrosis to endoplasmic reticulum stress: differential role of Grp78 and ATF6. Biochim. Biophys. Acta. 1772 (2007) 1236-1249
42. Pennec J.P., Talarmin H., Droguet M., Giroux-Metges M.A., Gioux M., and Dorange G. Characterization of the voltage-activated currents in cultured atrial myocytes isolated from the heart of the common oyster Crassostrea gigas. J. Exp. Biol. 207 (2004) 3935-3944
43. Prince L.S., Workman R.B., and Marchase R.B. Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 5192-5196
44. Ramjeesingh M., Kidd J.F., Huan L.J., Wang Y., and Bear C.E. Dimeric cystic fibrosis transmembrane conductance regulator exists in the plasma membrane. Biochem. J. 374 (2003) 793-797
45. Bensalem N., Ventura A.P., Vallee B., Lipecka J., Tondelier D., Davezac N., Dos S.A., Perretti M., Fajac A., Sermet-Gaudelus I., Renouil M., Lesure J.F., Halgand F., Laprevote O., and Edelman A. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol. Cell Proteomics 4 (2005) 1591-1601
46. L.A. Borthwick, J. McGaw, G. Conner, C.J. Taylor, V. Gerke, A. Mehta, L. Robson and R. Muimo, The formation of the cAMP/PKA-dependent Annexin 2-S100A10 complex with CFTR regulates CFTR channel function, Mol. Cell. Biol. (Ahead of print).
47. Della Gaspera G.B., Weinman S., Huber C., Lemnaouar M., Paul A., Picard J., and Gruenert D.C. Overexpression of annexin V in cystic fibrosis epithelial cells from fetal trachea. Exp. Cell Res. 219 (1995) 379-383
48. Stringer B., Imrich A., and Kobzik L. Lung epithelial cell A549 interaction with unopsonized environmental particulates: quantitation of particle-specific binding and IL-8 production. Exp. Lung Res. 22 (1996) 495-508
49. Gerke V., and Moss S.E. Annexins and membrane dynamics. Biochim. Biophys. Acta. 1357 (1997) 129-154
50. Creutz C.E. The annexins and exocytosis. Science 258 (1992) 924-931
51. Megli F.M., Selvaggi M., Liemann S., Quagliariello E., and Huber R. The calcium-dependent binding of annexin V to phospholipid vesicles influences the bilayer inner fluidity gradient. Biochemistry 37 (1998) 10540-10546
52. Jung G., Andrews D.M., Carraway K.L., and Carraway C.A. Actin-associated cell-surface glycoprotein from ascites cell microvilli: a disulfide-linked multimer. J. Cell Biochem. 28 (1985) 243-252
53. Giambanco I., Pula G., Bianchi R., and Donato R. Interaction of two brain annexins, CaBP33 and CaBP37, with membrane-skeleton proteins. FEBS Lett. 267 (1990) 171-175